CAS 192329-42-3 appears in our catalog under these names: Prinomastat, Prinomastat/ 99.23% (existing batch purity), Prinomastat (AG3340), Prinomastat 99%, prinomastat, 99.23% ,, 99.23% ,. Offered by: TRC, TargetMol, GLPBio, Biosynth, Ambeed. Available pack sizes: 500mg, 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 0,5g.
Prinomastat is a hydroxamic acid that is (3S)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide in which the hydrogen attached to the thiomorpholine nitrogen has been replaced by a [4-(pyridin-4-yloxy)phenyl]sulfonyl group. It is a selective inhibitor with of matrix metalloproteinases (MMPs) 2, 3, 9, 13, and 14. It has a role as an antineoplastic agent, a matrix metalloproteinase inhibitor and an EC 3.4.24.35 (gelatinase B) inhibitor. It is a hydroxamic acid, a member of pyridines, a sulfonamide, an aromatic ether and a member of thiomorpholines. It is a conjugate base of a prinomastat(1+).
Source: ChEBI
| Molecular formula | C18H21N3O5S2 |
|---|---|
| Molecular weight | 423.5 g/mol |
| IUPAC name | (3S)-N-hydroxy-2,2-dimethyl-4-(4-pyridin-4-yloxyphenyl)sulfonylthiomorpholine-3-carboxamide |
| InChIKey | YKPYIPVDTNNYCN-INIZCTEOSA-N |
| SMILES | CC1([C@@H](N(CCS1)S(=O)(=O)C2=CC=C(C=C2)OC3=CC=NC=C3)C(=O)NO)C |
Computed by PubChem (NCBI)